跳至主要内容
临床试验/CTRI/2017/11/010667
CTRI/2017/11/010667已完成4 期

COMPARISON OF INJECTABLE DEXAMETHASONE PLUS NEBULISED ADRENALINE & NEBULISED FLUTICASONE PLUS NEBULISED ADRENALINE & NEBULISED ADRENALINE ALONE IN PATIENTS OF BRONCHIOLITIS: A RANDOMISED OPEN LABEL COMPARATIVE CONTROL TRIA

Department of Pediatrics0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • All cases of bronchiolitis with a Respiratory Distress Assessment Instrument (RDAI) score of 4 to 15 [on a scale of 0 (mild) to 17 (severe)]
  • An RDAI score involves assigning a numerical value to 6 separate assessments; the sum of these scores provides an RDAI score ranging from 0 to 17, with increasing scores indicating increasing respiratory distress.

排除标准

  • 1. Who received oral or inhaled corticosteroids during the preceding 2 weeks.
  • 2. Previous diagnosis of asthma or Wheeze Associated Lower Respiratory Tract Infection.
  • 3. Chronic disease that may affect cardiopulmonary status of the patient, such as
  • Bronco pulmonary dysplasia
  • Cystic fibrosis
  • Congenital heart disease
  • Immune deficiency.
  • 4. Who are preterm with corrected age of less than 4 weeks at presentation
  • 5. Congenital malformation of respiratory and cardiovascular system
  • 6. Severe disease [clinical score > 15] requiring mechanical ventilation:
  • a. Saturation < 85% on room air, cyanosis, head bobbing,
  • b. Obtunded consciousness, and/or
  • c. Progressive respiratory failure.

研究者

相似试验